Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Mar 5;95:107531. doi: 10.1016/j.intimp.2021.107531

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 Elsevier B.V. All rights reserved.

Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

PMC Copyright notice

Fig 2 — The dynamic changes in selected inflammatory and immunological parameters during the course of COVID-19. (A), the antibiotic treatment of patients in different probiotics treated groups; (B), the dynamic change of IL-6 in patients in different probiotics treated groups; (C), the dynamic change of CRP level in patients in different probiotics treated groups; (D), the dynamic change of total T lymphocytes in patients in different probiotics treated groups; (E), the dynamic change of NK cells in patients in different probiotics treated groups; (F), the dynamic change of B lymphocytes in patients in different probiotics treated groups; (G), the dynamic change of CD4 + T cells in patients in different probiotics treated groups; (H), the dynamic change of CD8 + T cells in patients in different probiotics treated groups; (I), the dynamic change of CD4/CD8 ratio in patients in different probiotics treated groups.